Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Comparisons and related research compounds
Participants taking a daily dose of 50 mg of oral semaglutide experienced up to a 15.1% reduction in body weight
Phase 3 trials are underway, and a realistic approval window is late 2026 at the earliest, more likely 2027
Association between plasma uric acid and insulin resistance in type 2 diabetes: A Mendelian randomization analysis
US$ 25.49
US$ 26.68
US$ 28.31
US$ 22.24
US$ 20.94
US$ 22.81
US$ 21.44
